The new paradigm: assessing airway inflammation rather than diagnostic labelling is a movement not a fad

I. Pavord (Leicester, United Kingdom)

Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease
Disease area: Airway diseases

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Pavord (Leicester, United Kingdom). The new paradigm: assessing airway inflammation rather than diagnostic labelling is a movement not a fad. Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Roles of bronchoscopy and noninvasive measurements of airway inflammation in evaluating chronic cough: the role of noninvasive measurements of airway inflammation
Source: Annual Congress 2007 - PG23 - Managing chronic cough: guidelines and controversies (jointly organised with ACCP)
Year: 2007



Mucosal cryobiopsies – a new method for studying airway pathology in asthma
Source: Virtual Congress 2021 – Bronchoscopy in the COVID - 19 era: cryobiopsy
Year: 2021


Clinical applications of assessment of airway inflammation using induced sputum
Source: Eur Respir J 2002; 20: 40S-43S
Year: 2002


Role of airway responsivenes in asthma monitoring: new horizons
Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment
Year: 2006



Airway inflammation in COPD: physiological outcome measures and induced sputum
Source: Eur Respir J 2003; 21: 19S-28S
Year: 2003



Clinical use of induced sputum in the management of asthma. A noninvasive measurements of airway
Source: Annual Congress 2007 - Assessing asthma severity and control in children
Year: 2007


Investigation and assessment of airway and lung inflammation: we now have the tools, what are the questions?
Source: Guideline 1998
Year: 1998

Galectn-3 : marker of airway inflammation in bronchial asthma
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018


Patterns of inflammation and the use of reversibility testing in smokers with airway complaints: The COOPT sputum induction study
Source: Eur Respir J 2003; 22: Suppl. 45, 69s
Year: 2003

Safety of airway clearance techniques, sputum induction and bronchoscopy in severe asthma
Source: International Congress 2017 – Bronchial asthma management
Year: 2017

Are we ready to monitor inflammation and remodelling in asthma?
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Year: 2005

Can airway resistance, measured by the interrupter technique, be useful in evaluating the methacholine bronchial challenge test in children?
Source: Eur Respir J 2004; 24: Suppl. 48, 585s
Year: 2004

Dose response of continuous positive airway pressure on nasal symptoms, obstruction and inflammation in vivo and in vitro
Source: Eur Respir J 2012; 40: 1180-1190
Year: 2012



Treatment: how does inflammatory phenotype influence response to treatment in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007


Mucosal cryobiopsies: A novel method for studying obstructive airways disease?
Source: International Congress 2017 – Innovation in COPD: techniques and facts
Year: 2017



Use of continuous positive airway pressure reduces airway reactivity in adults with asthma
Source: Eur Respir J 2013; 41: 317-322
Year: 2013



Targeting airway inflammation in asthma: current and future therapies
Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment
Year: 2009



Targeting airway inflammation in asthma: current and future therapies
Source: Annual Congress 2009 - MP7 - Targeting airway inflammation in asthma: current and future therapies
Year: 2009